EQA PLACED UNDER THE AEGIS OF THE FAEEQ |
1 - OVERVIEW
The 6 non-profit associations (declared according to the law of July 1, 1901) members of the FAEEQ "Federation of EQA Associations", namely Asqualab, Association de Biologie Praticienne, Biologie Prospective, CTCB, GBMHM and ProBioQual, wished offer to their customers a list of EQAs placed under the aegis of the FAEEQ.
If you wish to have the list of these EQAs and all the related information, we invite you to consult the website www.faeeq.fr.
2 - LIST OF THESCHEMES
For more information about these EQAs Schemes, we invite you to contact the Managing Associations directly and register with these organizations.
TITLE OF THE EQA | MANAGEMENT PROVIDED BY |
Specialized antibiotics | ASQUALAB :
Tel: +33 (0)1 45 40 35 75 E-mail: asqualab@wanadoo.fr Website: https://www.asqualab.com/ |
β-lactam and penems antibiotics | |
Cytostasis - Tyrosine kinase inhibitor | |
Newborn screening | |
Fetal RhD genotyping | |
Hydroxychloroquine and metabolites (whole blood and serum) | |
Hydroxychloroquine, Chloroquine and Metabolites
(whole blood and serum) |
|
Kleihauer–Betke test | |
Uracilemia | |
Vitamins and Biofactors in whole Blood | |
Vitamins and Biofactors in serum | |
Urine test strip | BIOLOGIE PROSPECTIVE :
Tel: +33 (0)3 83 44 51 41 E-mail: contact@biologie-prospective.org Website: https://www.biologie-prospective.org/ |
Biotherapy: Tocilizumab | |
CDT (Carbohydrate deficient transferrin) | |
Functional coprology (biochemistry) | |
Cytology of body fluids | |
Lymph node cytology | |
Flow Cytometry in Hematological Disorders | |
POCT in hemostasis: INR and ACT in whole blood | |
MAR-Test (Mixed Antiglobulin Reaction) | |
Mycology (filamentous fungi - yeasts): direct examination | |
SARS-CoV-2 serology | |
Postcoital test (Sims-Huhner test) | |
Pathological erythrocyte sedimentation rate | |
SARS-CoV-2 RNA (molecular virology) | CTCB :
Tel: +33 (0)5 34 51 49 80 E-mail: secretariat.ctcb@ctcb.com Website: https://www.ctcb.com/ |
Biotherapy: Adalimumab / Infliximab / Rituximab / Vedolizumab / Ustekinumab | |
Angiotensin-converting enzyme | |
One-Step Nucleic Acid Amplification (OSNA) | |
PCR Clostridium difficile | |
CSF Virus PCR | |
PCR in neonatal and adult meningitis | |
Stool PCR | |
PCR Staphylococcus aureus (MSSA et MRSA) | |
PCR - Detection of Staphylococcus aureus toxins | |
Seminal plasma | |
Blood in stool | |
Research and/or quantification of molecular markers in the context of CML and ALL (BCR::ABL1) | GBMHM :
Tel: +33 (0)1 42 49 40 28 E-mail: contact-eeq@gbmhm.fr Website: http://www.gbmhm.fr/ |
Research and/or quantification of molecular markers in the context of Ph- MPNs (Calreticulin and JAK2) | |
Research and/or quantification of molecular markers in the context of AML (NPM1a, FLT3 ITD, TP53, CBFB::MYH11 and RUNX1::RUNX1T1) | |
Research for molecular markers in CLL (TP53 and analysis of IGHV mutation status) | |
Research and/or quantification of molecular markers in the context of Lymphoma (MYD88 and lymphoid clonality analysis) | |
Research for mutations by next-generation sequencing (NGS) for myeloid and lymphoid haemopathies |
| Politique de Confidentialité | Conditions Générales de Vente | | Dernière mise à jour : 04/09/2023 | Copyright © 2011-2023 ProBioQual Tous droits réservés |